Key stats
Market capitalization
4.051MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
0.68
Basic EPS (TTM)
−7.72USD
About 180 Life Sciences Corp
ISIN
US68236V2034
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
180lifesciences.com
CEO
Jim N. Woody
Headquarters
Palo Alto
Employees
7
Founded
2016
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0